Welche Schutzmaske schützt vor COVID-19? Was ist evidenzbasiert?

Die COVID-19-Pandemie hat sowohl in der Patientenversorgung als auch in der Öffentlichkeit zu Diskussionen geführt, mit welchen Schutzmasken man sich vor einer Ansteckung schützen kann. Ähnliche Diskussionen hatte es schon 2009/10 im Rahmen der damals weltweiten Ausbreitung einer neuen Variante des Influenzavirus A (H1N1) gegeben („Schweinegrippe“). Auffällig sind damals wie heute Unklarheiten und Verwirrungen in Bezug auf die Übertragungswege von Atemwegsinfektionen und über die sich daraus ableitenden Schutzmaßnahmen.

Publication History

Article published online:
28 August 2020

• Literatur

• 1 World Health Organization (WHO). Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care.Genève: World Health Organization; 2014. Im Internet: www.who.int/csr/bioriskreduction/infection_control/publication/en; (Stand: 26.04.2020)
• 2 Siegel JD, Rhinehart E. et al. the Healthcare Infection Control Practices Advisory Committee 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Im Internet: www.cdc.gov/infectioncontrol/guidelines/isolation/index.html (Stand: 26.04.2020)
• 3 Schulze-Röbbecke R. Nosokomialer Infektionen: Übertragungswege und Übertragungsprävention. Krankenhaushygiene up2date 2018; 13: 63-75
• 4 Xie X, Li Y, Chwang ATY. et al. How far droplets can move in indoor environments – revisiting the Wells evaporation-falling curve. Indoor Air 2007; 17: 211-225
• 5 Cole EC, Cook CE. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control 1998; 26: 453-464
• 6 Tang JW. The effect of environmental parameters on the survival of airborne infectious agents. J R Soc Interface 2009; 6 (Suppl 06): 737-746
• 7 Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut Infektionsprävention im Rahmen der Pflege und Behandlung von Patienten mit übertragbaren Krankheiten. Bundesgesundheitsbl 2015; 58: 1151-1170. DOI: 10.1007/s00103-015-2234-2.
• 8 MacIntyre CR, Seale H, Dung TC. et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015; 5: e006577. DOI: 10.1136/bmjopen-2014-006577.
• 9 Robert-Koch-Institut. Empfehlungen des RKI zu Hygienemaßnahmen im Rahmen der Behandlung und Pflege von Patienten mit einer Infektion durch SARS-CoV-2. Im Internet www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Hygiene.html (Stand: 14.04.2020)
• 10 Ausschuss für Biologische Arbeitsstoffe (ABAS). Technische Regeln für Biologische Arbeitsstoffe, TRBA 250 – Biologische Arbeitsstoffe im Gesundheitswesen und in der Wohlfahrtspflege. GMBl 2014, Nr. 10/11 vom 27.03.2014; 4. Änderung vom 2.5.2018, Nr. 15. GMBl; 2014. Im Internet: www.baua.de/DE/Angebote/Rechtstexte-und-Technische-Regeln/Regelwerk/TRBA/TRBA-250.html; (Stand: 26.04.2020)
• 11 Occupational Safety and Health Administration. Hospital Respiratory Protection Program Toolkit Resources for Respirator Program Administrators. May 2015 Im Internet www.osha.gov/Publications/OSHA3767.pdf; (Stand: 26.04.2020)
• 12 Ziegler R, Just H-M, Castell S. et al. Infektionsprävention bei Tuberkulose: Empfehlungen des DZK. Pneumologie 2012; 66: 269-282
• 13 Schünemann H, Brożek J, Guyatt G. et al. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013.. Im Internet: https://gdt.gradepro.org/app/handbook/handbook.html; (Stand: 26.04.2020)
• 14 Tran K, Cimon K, Severn M. et al. Aerosol-Generating Procedures and Risk of Transmission of Acute Respiratory Infections: A Systematic Review. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011. Im Internet: www.cadth.ca/media/pdf/M0023_Aerosol_Generating_Procedures_e.pdf; (Stand: 26.04.2020)
• 15 World Health Organization. Interim guidance: Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, 19 March 2020. Im Internet: www.who.int/publicationsdetail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125; (Stand: 26.04.2020)
• 16 Nam HS, Yeon MY, Park JW. et al. Healthcare worker infected with Middle East respiratory syndrome during cardiopulmonary resuscitation in Korea, 2015. Epidemiology and health 2017; 39: e2017052
• 17 Public Health England. Guidance: COVID-19 personal protective equipment (PPE), updated 17 April 2020 Im Internet: www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-preventionand-control/covid-19-personal-protective-equipment-ppe; (Stand: 21.04.2020)
• 18 Jefferson T, Del Mar CB, Dooley L. et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2011; 7: CD006207. DOI: 10.1002/14651858. .CD006207.pub4
• 19 Robert Koch-Institut. Nationaler Pandemieplan Teil II – Wissenschaftliche Grundlagen. Berlin: RKI; 2016. Im Internet: doi:10.17886/rkipubl-2016-004.5. www.rki.de/DE/Content/ InfAZ/I/Influenza/Pandemieplanung/Downloads/Pandemieplan_ Teil_II_gesamt.html; (Stand: 26.04.2020)
• 20 Smith JD, MacDougall CC, Johnstone J. et al. Effectiveness of N95 Respirators Versus Surgical Masks in Protecting Health Care Workers From Acute Respiratory Infection: A Systematic Review and Meta-Analysis. CMAJ 2016; 188: 567-574. DOI: 10.1503/cmaj.150835.
• 21 Offeddu V, Yung CF, Low MSF. et al. Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis. Clin Infect Dis 2017; 65: 1934-1942. DOI: 10.1093/cid/cix681.
• 22 Bartoszko JJ, Farooqi MAM, Alhazzani W. et al. Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials [im Druck]. Influenza Other Respir Viruses 2020; DOI: 10.1111/irv.12745.
• 23 Radonovich LJ, Simberkoff MS, Bessesen MT. et al. N95 respirators vs. medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA 2019; 322: 824-833 DOI: 10.1001/jama.2019.11645.
• 24 Thompson KA, Pappachan JV, Bennett AM. et al. Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic – the risk of aerosol generation during medical procedures. PLoS One 2013; 8: e56278 DOI: 10.1371/journal.pone.0056278.
• 25 O'Neil CA, Jiayu L, Leavey A. et al. Characterization of aerosols generated during patient care activities. Clinical Infectious Diseases 2017; 65: 1335-1341 DOI: 10.1093/cid/cix535.
• 26 Marchand G, Duchaine C, Lavoie J. et al. Bacteria emitted in ambient air during bronchoscopy – a risk to health care workers?. American Journal of Infection Control 2016; 44: 1634-1638 DOI: 10.1016/j.ajic.2016.04.241.
• 27 Leung CCH, Joynt GM, Gomersall CD. et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019; 101: 84-87. DOI: 10.1016/j.jhin.2018.10.007.
• 28 van Doremalen N, Bushmaker T, Morris DH. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New Engl J Med 2020; 382: 1564-1567. DOI: 10.1056/NEJMc2004973.
• 29 Bae S, Kim MC, Kim JY. et al. Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled comparison in 4 patients. Ann Intern Med 2020; M20-1342. DOI: 10.7326/M20-1342.
• 30 Guo ZD, Wang ZY, Zhang SF. et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 [im Druck]. Emerg Infect Dis 2020; DOI: 10.3201/eid2607.200885.
• 31 Ong SWX, Tan YK, Chia PY. et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient [im Druck]. JAMA 2020; e203227. DOI: 10.1001/jama.2020.3227.
• 32 Leung NHL, Chu DKW, Shiu EYC. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Medicine 2020; DOI: 10.1038/s41591-020-0843-2.
• 33 Chia PY, Coleman KK, Tan YK. et al. Detection of air and surface contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospital rooms of infected patients. medRxiv 2020; DOI: 10.1101/2020.03.29.20046557.
• 34 Santarpia JL, Rivera DN, Herrera V. et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the university of Nebraska Medical Center. medRxiv 2020; DOI: 10.1101/2020.03.23.20039446.
• 35 Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should face the reality [im Druck]. Environment International 2020; 139 DOI: 10.1016/j.envint.2020.105730.
• 36 Lewis D. Is the Coronavirus airborne? Experts can’t agree. Nature 2020; 580: 175. doi:10.1038/d41586-020-00974-w
• 37 Brainard JS, Jones N, Lake I. et al. Facemasks and similar barriers to prevent respiratory illness such as COVID-19: a rapid systematic review. medRxiv 2020; DOI: 10.1101/2020.04.01.20049528.
• 38 World Health Organization Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza. 2019; Licence: CC BYNC-SA 3.0 IGO
• 39 Mahase E. Covid-19: What is the evidence for cloth masks?. BMJ 2020; 369: m1422 doi:10.1136/bmj.m1422